Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Current Cardiology Reports
Erschienen in: Current Cardiology Reports 6/2018

01.06.2018 | Ischemic Heart Disease (D Mukherjee, Section Editor)

Current Endovascular Approach to the Management of Acute Ischemic Stroke

verfasst von: Rakesh Khatri, Anantha R. Vellipuram, Alberto Maud, Salvador Cruz-Flores, Gustavo J. Rodriguez

Erschienen in: Current Cardiology Reports | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The review provides an overview of current endovascular management of patients with acute ischemic stroke in the light of recent landmark trials proving unequivocal benefit of the intervention.

Recent Findings

Several randomized trials looking at selective groups of patients presenting after an acute ischemic stroke due to large vessel occlusion in the anterior circulation demonstrated an overwhelming benefit of the endovascular treatment compared to intravenous thrombolysis, leading to expedited changes in the American Heart Association/American Stroke Association guidelines. Nonetheless, there are a relative large number of patients that were not included in those trials that might still benefit from endovascular treatment (acute posterior circulation-related strokes or acute embolic occlusion of middle cerebral artery beyond the main trunk for instances) and in which further studies are needed. We also briefly discuss endovascular techniques, post-procedure care, and endovascular treatment delivery models to expedite stroke patient assessment and rapid transport using updated and improved workflow protocols to provide timely recanalization.

Summary

Endovascular treatment of acute occlusion of a proximal large artery in the anterior circulation is currently the standard of care. Time and quality of recanalization are the most important variables that determine the outcome. The indication for endovascular therapy in different scenarios (acute embolic occlusion in the posterior circulation or more distal branch occlusions) has to be individualized according to each patient’s particular characteristics until new evidence is provided.
Literatur
1.
Rothwell PM, Coull AJ, Silver LE, Fairhead JF, Giles MF, Lovelock CE, et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet (Lond). 2005;366(9499):1773–83.CrossRef
2.
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–322.CrossRefPubMed
3.
Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013;368(10):893–903.CrossRefPubMedPubMedCentral
4.
Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372(11):1019–30.CrossRefPubMed
5.
Bhatia R, Hill MD, Shobha N, Menon B, Bal S, Kochar P, et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke. 2010;41(10):2254–8.CrossRefPubMed
6.
del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke. 1998;29(1):4–11.CrossRefPubMed
7.
Ciccone A, Valvassori L, Nichelatti M, Sgoifo A, Ponzio M, Sterzi R, et al. Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013;368(10):904–13.CrossRefPubMedPubMedCentral
8.
Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013;368(10):914–23.CrossRefPubMedPubMedCentral
9.
•• Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372(1):11–20. This first landmark study which demonstrated efficacy of mechanical thromectomy up to 6 hours using stent retrivers.CrossRefPubMed
10.
Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372(24):2285–95.CrossRefPubMed
11.
Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372(11):1009–18.CrossRefPubMed
12.
Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372(24):2296–306.CrossRefPubMed
13.
Sardar P, Chatterjee S, Giri J, Kundu A, Tandar A, Sen P, et al. Endovascular therapy for acute ischaemic stroke: a systematic review and meta-analysis of randomized trials. Eur Heart J. 2015;36(35):2373–80.CrossRefPubMed
14.
•• Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46–e110. It covers previous landmark trials and other pertinenet management issues.
15.
Powers WJ, Derdeyn CP, Biller J, Coffey CS, Hoh BL, Jauch EC, et al. 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(10):3020–35.CrossRefPubMed
16.
• Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378(1):11–21. This study was first randomized study to demonstrate efficacy of mechanical thrombectomy after 6 hours up to 24 hours from symptoms onset using perfusion imaging. CrossRefPubMed
17.
Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New Engl J Med. 2018;378(8):708–18.
18.
Nadeau JO, Shi S, Fang J, Kapral MK, Richards JA, Silver FL, et al. TPA use for stroke in the Registry of the Canadian Stroke Network. Can J Neurol Sci. 2005;32(4):433–9.CrossRefPubMed
19.
Marler JR, et al. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581–7.CrossRef
20.
Moradiya Y, Janjua N. Presentation and outcomes of “wake-up strokes” in a large randomized stroke trial: analysis of data from the International Stroke Trial. J Stroke Cerebrovasc Dis. 2013;22(8):e286–92.CrossRefPubMed
21.
Costa R, Pinho J, Alves JN, Amorim JM, Ribeiro M, Ferreira C. Wake-up stroke and stroke within the therapeutic window for thrombolysis have similar clinical severity, imaging characteristics, and outcome. J Stroke Cerebrovasc Dis. 2016;25(3):511–4.CrossRefPubMed
22.
Silva GS, Lima FO, Camargo EC, Smith WS, Singhal AB, Greer DM, et al. Wake-up stroke: clinical and neuroimaging characteristics. Cerebrovasc Dis (Basel). 2010;29(4):336–42.CrossRef
23.
Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol. 2006;60(5):508–17.CrossRefPubMed
24.
Nagakane Y, Christensen S, Brekenfeld C, Ma H, Churilov L, Parsons MW, et al. EPITHET: positive result after reanalysis using baseline diffusion-weighted imaging/perfusion-weighted imaging co-registration. Stroke. 2011;42(1):59–64.CrossRefPubMed
25.
Barreto AD, Fanale CV, Alexandrov AV, Gaffney KC, Vahidy FS, Nguyen CB, et al. Prospective, open-label safety study of intravenous recombinant tissue plasminogen activator in wake-up stroke. Ann Neurol. 2016;80(2):211–8.CrossRefPubMed
26.
Amiri H, Bluhmki E, Bendszus M, Eschenfelder CC, Donnan GA, Leys D, et al. European Cooperative Acute Stroke Study-4: extending the time for thrombolysis in emergency neurological deficits ECASS-4: ExTEND. Int J Stroke. 2016;11(2):260–7.CrossRefPubMed
27.
Smith EE, Schwamm LH. Endovascular clot retrieval therapy: implications for the organization of stroke systems of care in North America. Stroke. 2015;46(6):1462–7.CrossRefPubMed
28.
Altenbernd J, Kuhnt O, Hennigs S, Hilker R, Loehr C. Frontline ADAPT therapy to treat patients with symptomatic M2 and M3 occlusions in acute ischemic stroke: initial experience with the Penumbra ACE and 3MAX reperfusion system. J Neurointerv Surg 2018;10(5)434–9.
29.
Haussen DC, Lima A, Nogueira RG. The Trevo XP 3x20 mm retriever (‘Baby Trevo’) for the treatment of distal intracranial occlusions. J Neurointerv Surg. 2016;8(3):295–9.CrossRefPubMed
30.
Dababneh H, Guerrero WR, Khanna A, Hoh BL, Mocco J. Management of tandem occlusion stroke with endovascular therapy. Neurosurg Focus. 2012;32(5):E16.CrossRefPubMed
31.
Kistler JP, Ropper AH, Heros RC. Therapy of ischemic cerebral vascular disease due to atherothrombosis. (2). N Engl J Med. 1984;311(2):100–5.CrossRefPubMed
32.
Heck DV, Brown MD. Carotid stenting and intracranial thrombectomy for treatment of acute stroke due to tandem occlusions with aggressive antiplatelet therapy may be associated with a high incidence of intracranial hemorrhage. J Neurointerv Surg. 2015;7(3):170–5.CrossRefPubMed
33.
Aghaebrahim A, Jovin T, Jadhav AP, Noorian A, Gupta R, Nogueira RG. Endovascular recanalization of complete subacute to chronic atherosclerotic occlusions of intracranial arteries. J Neurointerv Surg. 2014;6(9):645–8.CrossRefPubMed
34.
Mbabuike N, Gassie K, Brown B, Miller DA, Tawk RG. Revascularization of tandem occlusions in acute ischemic stroke: review of the literature and illustrative case. Neurosurg Focus. 2017;42(4):E15.CrossRefPubMed
35.
Sivan-Hoffmann R, Gory B, Armoiry X, Goyal M, Riva R, Labeyrie PE, et al. Stent-retriever thrombectomy for acute anterior ischemic stroke with tandem occlusion: a systematic review and meta-analysis. Eur Radiol. 2017;27(1):247–54.CrossRefPubMed
36.
Nguyen TN, Malisch T, Castonguay AC, Gupta R, Sun CH, Martin CO, et al. Balloon guide catheter improves revascularization and clinical outcomes with the Solitaire device: analysis of the North American Solitaire Acute Stroke Registry. Stroke. 2014;45(1):141–5.CrossRefPubMed
37.
Dorn F, Stehle S, Lockau H, Zimmer C, Liebig T. Endovascular treatment of acute intracerebral artery occlusions with the solitaire stent: single-centre experience with 108 recanalization procedures. Cerebrovasc Dis (Basel). 2012;34(1):70–7.CrossRef
38.
Lapergue B, Blanc R, Guedin P, Decroix JP, Labreuche J, Preda C, et al. A direct aspiration, first pass technique (ADAPT) versus stent retrievers for acute stroke therapy: an observational comparative Study. AJNR Am J Neuroradiol. 2016;37(10):1860–5.
39.
Lapergue B, Blanc R, Gory B, Labreuche J, Duhamel A, Marnat G, et al. Effect of endovascular contact aspiration vs stent retriever on revascularization in patients with acute ischemic stroke and large vessel occlusion: the ASTER randomized clinical trial. JAMA. 2017;318(5):443–52.CrossRefPubMedPubMedCentral
40.
Lowhagen Henden P, Rentzos A, Karlsson JE, Rosengren L, Leiram B, Sundeman H, et al. General anesthesia versus conscious sedation for endovascular treatment of acute ischemic stroke: the AnStroke trial (Anesthesia During Stroke). Stroke. 2017;48(6):1601–7.CrossRefPubMed
41.
Nikolaus T, Jamour M. Effectiveness of special stroke units in treatment of acute stroke. Z Gerontol Geriatr. 2000;33(2):96–101.PubMed
42.
Yoon W, Seo JJ, Kim JK, Cho KH, Park JG, Kang HK. Contrast enhancement and contrast extravasation on computed tomography after intra-arterial thrombolysis in patients with acute ischemic stroke. Stroke. 2004;35(4):876–81.CrossRefPubMed
43.
Payabvash S, Qureshi MH, Khan SM, Khan M, Majidi S, Pawar S, et al. Differentiating intraparenchymal hemorrhage from contrast extravasation on post-procedural noncontrast CT scan in acute ischemic stroke patients undergoing endovascular treatment. Neuroradiology. 2014;56(9):737–44.CrossRefPubMed
44.
Fiorelli M, Bastianello S, von Kummer R, del Zoppo GJ, Larrue V, Lesaffre E, et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke. 1999;30(11):2280–4.CrossRefPubMed
45.
Gupta R, Cheung AC, Bartling SH, Lisauskas J, Grasruck M, Leidecker C, et al. Flat-panel volume CT: fundamental principles, technology, and applications. Radiographics Rev Publ Radiol Soc North Am Inc. 2008;28(7):2009–22.
46.
Payabvash S, Khan AA, Qureshi MH, Saeed O, Suri MF, Qureshi AI. Detection of intraparenchymal hemorrhage after endovascular therapy in patients with acute ischemic stroke using immediate postprocedural flat-panel computed tomography scan. J Neuroimaging Off J Am Soc Neuroimaging. 2016;26(2):213–8.CrossRef
47.
Jang YM, Lee DH, Kim HS, Ryu CW, Lee JH, Choi CG, et al. The fate of high-density lesions on the non-contrast CT obtained immediately after intra-arterial thrombolysis in ischemic stroke patients. Korean J Radiol. 2006;7(4):221–8.CrossRefPubMedPubMedCentral
48.
Ferda J, Novak M, Mirka H, Baxa J, Ferdova E, Bednarova A, et al. The assessment of intracranial bleeding with virtual unenhanced imaging by means of dual-energy CT angiography. Eur Radiol. 2009;19(10):2518–22.CrossRefPubMed
49.
Renu A, Amaro S, Laredo C, Roman LS, Llull L, Lopez A, et al. Relevance of blood-brain barrier disruption after endovascular treatment of ischemic stroke: dual-energy computed tomographic study. Stroke. 2015;46(3):673–9.CrossRefPubMed
50.
Dinkel J, Khalilzadeh O, Phan CM, Goenka AH, Yoo AJ, Hirsch JA, et al. Technical limitations of dual-energy CT in neuroradiology: 30-month institutional experience and review of literature. J Neurointerv Surg. 2015;7(8):596–602.CrossRefPubMed
51.
Mattle HP, Kappeler L, Arnold M, Fischer U, Nedeltchev K, Remonda L, et al. Blood pressure and vessel recanalization in the first hours after ischemic stroke. Stroke. 2005;36(2):264–8.CrossRefPubMed
52.
Mistry EA, Mistry AM, Nakawah MO, Khattar NK, Fortuny EM, Cruz AS, et al. Systolic blood pressure within 24 hours after thrombectomy for acute ischemic stroke correlates with outcome. J Am Heart Assoc. 2017;6(5):e006167.CrossRefPubMedPubMedCentral
53.
Leslie-Mazwi T, Rabinov J, Hirsch JA. Endovascular treatment of acute ischemic stroke. Handb Clin Neurol. 2016;136:1293–302.CrossRefPubMed
54.
Schulz-Schupke S, Helde S, Gewalt S, Ibrahim T, Linhardt M, Haas K, et al. Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial. JAMA. 2014;312(19):1981–7.CrossRefPubMed
55.
Elmasri MA, Kee ST, Moriarty JM, Gomes A, Lee EW, McWilliams JP. Single-center comparison of the efficacy and complications of arterial vascular closure devices in interventional radiology. J Vascular Access. 2017;18(4):339–44.CrossRef
56.
Belagaje SR, Zander K, Thackeray L, Gupta R. Disposition to home or acute rehabilitation is associated with a favorable clinical outcome in the SENTIS trial. J Neurointerv Surg. 2015;7(5):322–5.CrossRefPubMed
57.
58.
Carrera D, Campbell BC, Cortes J, Gorchs M, Querol M, Jimenez X, et al. Predictive value of modifications of the prehospital rapid arterial occlusion evaluation scale for large vessel occlusion in patients with acute stroke. J Stroke Cerebrovasc Dis. 2017;26(1):74–7.CrossRefPubMed
59.
Mehta BP, Leslie-Mazwi TM, Chandra RV, Bell DL, Sun CH, Hirsch JA, et al. Reducing door-to-puncture times for intra-arterial stroke therapy: a pilot quality improvement project. J Am Heart Assoc. 2014;3(6):e000963.CrossRefPubMedPubMedCentral
60.
Kleindorfer D, Xu Y, Moomaw CJ, Khatri P, Adeoye O, Hornung R. US geographic distribution of rt-PA utilization by hospital for acute ischemic stroke. Stroke. 2009;40(11):3580–4.CrossRefPubMed
61.
Fassbender K, Balucani C, Walter S, Levine SR, Haass A, Grotta J. Streamlining of prehospital stroke management: the golden hour. Lancet Neurol. 2013;12(6):585–96.CrossRefPubMed
62.
Parker SA, Bowry R, Wu TC, Noser EA, Jackson K, Richardson L, et al. Establishing the first mobile stroke unit in the United States. Stroke. 2015;46(5):1384–91.CrossRefPubMed
63.
Higashida R, Alberts MJ, Alexander DN, Crocco TJ, Demaerschalk BM, Derdeyn CP, et al. Interactions within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association. Stroke. 2013;44(10):2961–84.CrossRefPubMed
Metadaten
Titel
Current Endovascular Approach to the Management of Acute Ischemic Stroke
verfasst von
Rakesh Khatri
Anantha R. Vellipuram
Alberto Maud
Salvador Cruz-Flores
Gustavo J. Rodriguez
Publikationsdatum
01.06.2018
Verlag
Springer US
Erschienen in
Current Cardiology Reports / Ausgabe 6/2018
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-018-0989-4

Weitere Artikel der Ausgabe 6/2018

Current Cardiology Reports 6/2018 Zur Ausgabe

Structural Heart Disease (RJ Siegel and NC Wunderlich, Section Editors)

Current State of Left Atrial Appendage Closure

Nuclear Cardiology (V Dilsizian, Section Editor)

Perspectives on Current Training Guidelines for Cardiac Imaging and Recommendations for the Future

Pericardial Disease (AL Klein, Section Editor)

The Role of Epicardial Fat in Pericardial Diseases

Interventional Cardiology (SR Bailey, Section Editor)

The Various Applications of 3D Printing in Cardiovascular Diseases

Invasive Electrophysiology and Pacing (EK Heist, Section Editor)

The Saga of Defibrillation Testing: When Less Is More

Structural Heart Disease (RJ Siegel and NC Wunderlich, Section Editors)

Mitral Valve Interventions in Structural Heart Disease

Neu im Fachgebiet Kardiologie

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise